You are here: Industry Insights > china

News List

Cellular Biomedicine Group Enters Into Strategic Licensing and Collaboration Agreement with a Global Leader in CAR-T Cell Therapy for Patients in China pharmafocusasia
September 29, 2018
Cellular Biomedicine Group Inc today announced it has entered into a strategic licensing and collaboration agreement with Novartis to manufacture and supply the CAR-T cell therapy Kymriah® (tisagenlecleucel) in China. Novartis will be the exclusive holder
Novo Nordisk to lay off 400 employees in Denmark and China pharmaceutical-technology
September 25, 2018
Novo Nordisk has announced plans to lay off around 400 staff in research and development (R&D) roles at its China and Denmark sites as part of its R&D restructuring strategy.
Novo Nordisk to lay off 400 employees in Denmark and China pharmaceutical-technology
September 21, 2018
Novo Nordisk has announced plans to lay off around 400 staff in research and development (R&D) roles at its China and Denmark sites as part of its R&D restructuring strategy.
AstraZeneca plots China robot offensive to counter price cuts expressbpd
September 21, 2018
With smart cancer diagnostics and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move from simply supplying drugs to becoming a broad healthcare provider in China
Allergan, eyeing Asia for growth, pours $14.7M into first medical aesthetics center in China fiercepharma
September 21, 2018
Allergan’s ambition for its medical aesthetics business is to grow to about $8 billion in 2025 from $3.8 billion in 2017 sales, with a big chunk coming from Asia.
AstraZeneca to increase presence in China pharmafile
September 20, 2018
The Anglo-Swedish multinational AstraZeneca is moving towards becoming a major healthcare provider in China as part of an effort to expand the overall market...
Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag fiercepharma
September 20, 2018
When Bristol-Myers Squibb unveiled its price for Opdivo in China, industry watchers considered it a benchmark against which future immuno-oncology therapies will look to for their pricing strategies.
China, Fiji ink pact for health and wellness biospectrumasia
September 19, 2018
Following the MoU signing, Fiji’s President Jioji Konrote renewed the call for a healthy, productive nation.
Invion to spinout respiratory assets, advance clinical development in China biospectrumasia
September 14, 2018
Invion completed feasibility, preclinical and clinical studies on its respiratory assets over three years to the end of 2015.
New drugs that have received conditional approval of marketing in China Erxiao
September 12, 2018
New drugs that have received conditional approval of marketing in China

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page